Filip Dubovsky, MD MPH

Dr. Dubovsky is president of research and development with responsibility for discovery, non-clinical and clinical research and development activities. Dr. Dubovsky brings more than 20 years vaccine development experience to Novavax. Dr. Dubovsky previously served as head of clinical engagement and policy and deputy chief medical officer for clinical affairs at AstraZeneca and oversaw the clinical development of early and late-stage infectious disease and vaccine assets at MedImmune (now AstraZeneca). He also created and managed a portfolio of 25 malaria vaccine candidates spanning early candidate optimization to Phase 3 clinical studies at PATH’s Malaria Vaccine Initiative. Dr. Dubovsky earned his Master of Public Health degree from Johns Hopkins University and his Doctor of Medicine degree from the University of Alabama. Completing his pediatric training at Stanford University, pediatric infectious disease fellowship at the Center for Vaccine Development at the University of Maryland, and preventive medicine training at Johns Hopkins University.